Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities

Qing Tong, Zhiqiang Cai

Open source

DOI
10.3389/fimmu.2026.1965726
Published
2026-10-19
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1965726,
  title = {Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities},
  author = {Qing Tong and Zhiqiang Cai},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1965726},
  url = {https://doi.org/10.3389/fimmu.2026.1965726}
}

RIS

TY  - JOUR
TI  - Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities
AU  - Qing Tong
AU  - Zhiqiang Cai
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1965726
UR  - https://doi.org/10.3389/fimmu.2026.1965726
ER  - 

APA

Tong, Q., & Cai, Z. (2026). Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1965726

Source records